Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 21, 2026Mini-Reviews in Medicinal Chemistry

Polymer-doxorubicin Conjugates: Redefining Chemotherapy for Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSneha KumariAKAman KumarMIM M Islam

Discussion

Loading...

Member takes

Overview

PDCs improve chemotherapy outcomes in breast cancer, suggesting a new approach to treatment.

Key Points

  • The research aims to develop polymer-doxorubicin conjugates to enhance the efficacy and safety of breast cancer chemotherapy.
  • Developed polymer drug conjugates with a biocompatible polymer backbone and cleavable linkers.
  • Investigated the mechanisms of tumor-specific release and reduction of cardiotoxicity.
  • Examined prototypes like HPMA-dox and PEG-dox for translational potential.
  • PDCs showed prolonged systemic persistence and better tumor accumulation due to enhanced permeability and retention effect.
  • Demonstrated reduced cardiotoxicity compared to traditional doxorubicin treatment.
  • Partially bypassed multidrug resistance mechanisms by utilizing endocytic pathways.

Cite This Study

Kumari et al. (2026) studied this question.

synapsesocial.com/papers/69e7138bcb99343efc98d104https://doi.org/10.2174/0113895575471485260408204857
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1pH-sensitive polymeric micelles enhance the co-delivery of doxorubicin and docetaxel: an emerging modality for treating breast cancer2024 · 36 citations
  2. 2Advances in Doxorubicin Chemotherapy: Emerging Polymeric Nanocarriers for Drug Loading and Delivery2025 · 39 citations
  3. 3DOX-Couped Polymeric Micelles as a State-of-the-Art Strategy Against Triple Negative Breast Cancer2024 · 1 citations
  4. 4Biometallic peptide-drug conjugates in photo-crosslinkable hydrogels enable combined photothermal-chemotherapy against breast cancer2026 · 1 citations
  5. 5Abstract 3026: A polymer-drug conjugate platform for tumor specific drug delivery: Advancement of a clinically validated ultra pH-sensitive micelle technology2026